hosts regular webinars on GLP-1 therapy free to attend
August 2021: Ozempic Could Be Linked to Increased Risk of Diabetic Retinopathy Study results examining diabetic retinopathy (DR) in patients taking semaglutide found a higher risk for DR complications in patients with proliferative and non-proliferative DR at baseline. However, researchers acknowledge that worsening DR could be due to rapid drops in blood glucose levels from diabetic medications
These are clinical observations, not controlled trial data
(PubMed) Clark WM, Wechsler LR, Sabounjian LA, Schwiderski UE, Citicoline Stroke Study Group
Weight loss can improve facial contours and reduce the appearance of wrinkles, complementing the effects of Botox
GLP-1 contributes to overall maintenance of glucose homeostasis through the reduction of glucagon secretion, while preclinical evidence suggests beneficial effects on pancreatic -cell proliferation, survival, and inhibition of apoptosis [34, 36, 37]